Trial Profile
International Multicentre, Observational, Non-Interventional Prospective Study of Azilsartan Medoxomil in Patients With Arterial Hypertension Who Are Overweight or Obese in the Russian Federation and The Republic of Kazakhstan
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 Aug 2021
Price :
$35
*
At a glance
- Drugs Azilsartan medoxomil (Primary)
- Indications Hypertension
- Focus Therapeutic Use
- Acronyms CONSTANT
- Sponsors Takeda
- 08 Jun 2018 Status changed from active, no longer recruiting to completed.
- 02 Nov 2017 Status changed from recruiting to active, no longer recruiting.
- 11 Sep 2017 Planned End Date changed from 1 Apr 2018 to 1 Sep 2018.